Related Experiment Video

Updated: Aug 7, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells

M J Elliott1, Y B Dong, H Yang

  • 1Department of Surgery, James Graham Brown Cancer Center, University of Louisville, 529 South Jackson Street, Louisville, KY 40202, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|November 14, 2001
PubMed

Insights

Overexpressing E2F-1 in colon cancer cells induced apoptosis and suppressed growth. This study clarifies E2F-1

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Therapy

Background:

  • The precise mechanisms by which E2F-1 induces apoptosis are not fully understood.
  • E2F-1 overexpression has shown potential in inducing apoptosis across various tumor cell lines.

Purpose of the Study:

  • To investigate the apoptotic effects of E2F-1 in colon cancer cells.
  • To elucidate the molecular mechanisms underlying E2F-1-mediated apoptosis in colon adenocarcinoma.

Main Methods:

  • Utilized adenoviral vectors to overexpress E2F-1 in HT-29 and SW-620 colon cancer cell lines.
  • Assessed cell growth, viability, cell cycle progression, and apoptosis markers (DNA fragmentation, caspase-3, PARP).
  • Analyzed protein expression levels of c-Myc, p14ARF, and Mcl-1 following E2F-1 overexpression.

Main Results:

  • E2F-1 overexpression significantly reduced cell growth and viability in both colon cancer cell lines.
  • Induced G2/M cell cycle arrest and increased sub-G1 populations, indicative of apoptosis.
  • Detected increased levels of c-Myc and p14ARF, and decreased levels of Mcl-1, alongside DNA fragmentation and apoptotic bodies.

Conclusions:

  • E2F-1 overexpression effectively triggers apoptosis and inhibits growth in colon adenocarcinoma cells.
  • The mechanism involves G2/M arrest, up-regulation of c-Myc and p14ARF, and down-regulation of Mcl-1.
  • E2F-1 demonstrates potential as a gene therapy agent for colon cancer treatment.

More Related Videos

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 13, 2013

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...